Reprogramming the cell material chromatin helped trigger beta-cell gene expression in alpha cells among human and mouse cells, according to a study in the Journal of Clinical Investigation. "This would be a win-win situation for diabetics -- they would have more insulin-producing beta cells and there would be fewer glucagon-producing alpha cells," said lead author Klaus H. Kaestner.